R01-CA39771/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1987	1
1988	1
1989	2
1994	1
1996	1
1997	1
1998	1
2005	1
2006	1
2008	1
2012	1
2015	2
2024	0

1

Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.

Fong CT, Brodeur GM. Fong CT, et al. Cancer Genet Cytogenet. 1987 Sep;28(1):55-76. doi: 10.1016/0165-4608(87)90354-2. Cancer Genet Cytogenet. 1987. PMID: 2955886 Review.

2

Clinical significance of genetic rearrangements in human neuroblastomas.

Brodeur GM. Brodeur GM. Clin Chem. 1989 Jul;35(7 Suppl):B38-42. Clin Chem. 1989. PMID: 2568197 Review.

3

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.

Higashi M, Kolla V, Iyer R, Naraparaju K, Zhuang T, Kolla S, Brodeur GM. Higashi M, et al. Mol Cancer. 2015 Aug 7;14:150. doi: 10.1186/s12943-015-0425-y. Mol Cancer. 2015. PMID: 26245651 Free PMC article.

4

The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.

Kolla V, Naraparaju K, Zhuang T, Higashi M, Kolla S, Blobel GA, Brodeur GM. Kolla V, et al. Biochem J. 2015 Jun 1;468(2):345-52. doi: 10.1042/BJ20150030. Biochem J. 2015. PMID: 25825869 Free PMC article.

5

Chromosome 1p and 11q deletions and outcome in neuroblastoma.

Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group. Attiyeh EF, et al. N Engl J Med. 2005 Nov 24;353(21):2243-53. doi: 10.1056/NEJMoa052399. N Engl J Med. 2005. PMID: 16306521 Free article.

6

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, et al. Brodeur GM, et al. J Clin Oncol. 1988 Dec;6(12):1874-81. doi: 10.1200/JCO.1988.6.12.1874. J Clin Oncol. 1988. PMID: 3199170

7

Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.

White PS, Maris JM, Sulman EP, Jensen SJ, Kyemba SM, Beltinger CP, Allen C, Kramer DL, Biegel JA, Brodeur GM. White PS, et al. Eur J Cancer. 1997 Oct;33(12):1957-61. doi: 10.1016/s0959-8049(97)00311-0. Eur J Cancer. 1997. PMID: 9516832

8

Mechanisms of CHD5 Inactivation in neuroblastomas.

Koyama H, Zhuang T, Light JE, Kolla V, Higashi M, McGrady PW, London WB, Brodeur GM. Koyama H, et al. Clin Cancer Res. 2012 Mar 15;18(6):1588-97. doi: 10.1158/1078-0432.CCR-11-2644. Epub 2012 Jan 31. Clin Cancer Res. 2012. PMID: 22294723 Free PMC article.

9

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.

Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM. Cole KA, et al. Mol Cancer Res. 2008 May;6(5):735-42. doi: 10.1158/1541-7786.MCR-07-2102. Mol Cancer Res. 2008. PMID: 18505919 Free PMC article.

10

A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal.

Smith EI, Haase GM, Seeger RC, Brodeur GM. Smith EI, et al. J Pediatr Surg. 1989 Apr;24(4):386-90. doi: 10.1016/s0022-3468(89)80277-5. J Pediatr Surg. 1989. PMID: 2732883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year